Great partners, well oversold, FDA approved, small float, lots o
This is worth owning at $1.33. Great partners in Roche and Genentech, lots of cash (55M), small float, and small debt. Bleed rate is also very small. Great potential here with this falling wedge pattern...
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。